Ishigaki Sayaka, Masui Kenichi, Kazama Tomiei
From the Department of Anesthesiology, National Defense Medical College, Tokorozawa, Saitama, Japan.
Anesth Analg. 2016 Mar;122(3):706-711. doi: 10.1213/ANE.0000000000001094.
Circulatory factors modify the onset time of neuromuscular-blocking drugs. Therefore, we hypothesized that infusion of a saline flush immediately after rocuronium administration would shorten the onset time without influencing the duration of the rocuronium effect.
Forty-eight patients were randomly allocated to the control or saline flush group. Anesthesia was induced and maintained with propofol and remifentanil, and all patients received 0.6 mg/kg rocuronium in 10 mL of normal saline. In the saline flush group, 20 mL normal saline was immediately infused after rocuronium administration. Neuromuscular blockade was assessed using acceleromyography at the adductor pollicis muscle with train-of-four (TOF) stimulation. The neuromuscular indices for rocuronium were calculated as follows: the latent onset time, defined as the time from the start of rocuronium infusion until first occurrence of depression of the first twitch of the TOF (T1) ≥5%; onset time, defined as the time from the start of rocuronium infusion until first occurrence of depression of the T1 ≥95%; clinical duration, defined as the time from the start of rocuronium administration until T1 recovered to 25% of the final T1 value; recovery index, defined as the time for recovery of T1 from 25% to 75% of the final T1 value; and the total recovery time, defined as the time from the start of rocuronium administration until reaching a TOF ratio of 0.9. Significance was designated at P <0.05.
The measured latent onset time and onset time were significantly shorter in the saline flush group than the control group by 15 seconds (95.2% confidence interval, 0-15, P = 0.007) and 15 seconds (0-30, P = 0.018), respectively. Saline flush significantly depressed the T1 height at 30, 45, and 60 seconds after the rocuronium bolus by 17%, 24%, and 14%, respectively. In addition, the recovery phase was significantly prolonged in the saline flush group. The mean clinical duration (5th-95th percentile range) in the saline flush group and control group was 35 minutes (27-63 minutes) and 31 minutes (19-48 minutes; P = 0.032), respectively; the recovery index was 13 minutes (8-25 minutes) and 10 minutes (7-19 minutes; P = 0.019), respectively; and the total recovery time was 61 minutes (44-108 minutes) and 50 minutes (35-93 minutes; P = 0.048), respectively.
Administering a 20-mL saline flush immediately after infusion of 0.6 mg/kg rocuronium in 10 mL normal saline shortened the onset time and prolonged the recovery phase of neuromuscular blockade.
循环因素可改变神经肌肉阻滞药物的起效时间。因此,我们推测在给予罗库溴铵后立即输注生理盐水冲洗液可缩短起效时间,且不影响罗库溴铵的作用持续时间。
48例患者被随机分配至对照组或生理盐水冲洗组。采用丙泊酚和瑞芬太尼诱导并维持麻醉,所有患者均接受10 mL生理盐水中含0.6 mg/kg罗库溴铵。在生理盐水冲洗组,罗库溴铵给药后立即输注20 mL生理盐水。使用加速度肌电图在拇收肌处进行四个成串刺激(TOF)来评估神经肌肉阻滞。罗库溴铵的神经肌肉指标计算如下:潜伏起效时间,定义为从开始输注罗库溴铵至TOF的第一个肌颤搐(T1)首次出现≥5%抑制的时间;起效时间,定义为从开始输注罗库溴铵至T1首次出现≥95%抑制的时间;临床持续时间,定义为从开始给予罗库溴铵至T1恢复至最终T1值的25%的时间;恢复指数,定义为T1从最终T1值的25%恢复至75%的时间;以及总恢复时间,定义为从开始给予罗库溴铵至TOF比值达到0.9的时间。P<0.05为有统计学意义。
生理盐水冲洗组测得的潜伏起效时间和起效时间分别比对照组显著缩短15秒(95.2%置信区间,0 - 15,P = 0.007)和15秒(0 - 30,P = 0.018)。生理盐水冲洗在罗库溴铵推注后30、45和60秒时分别使T1高度显著降低17%、24%和14%。此外,生理盐水冲洗组的恢复阶段显著延长。生理盐水冲洗组和对照组的平均临床持续时间(第5 - 95百分位数范围)分别为35分钟(27 - 63分钟)和31分钟(19 - 48分钟;P = 0.032);恢复指数分别为13分钟(8 - 25分钟)和10分钟(7 - 19分钟;P = 0.019);总恢复时间分别为61分钟(44 - 108分钟)和50分钟(35 - 93分钟;P = 0.048)。
在10 mL生理盐水中输注0.6 mg/kg罗库溴铵后立即给予20 mL生理盐水冲洗可缩短神经肌肉阻滞的起效时间并延长恢复阶段。